These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9629596)

  • 1. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
    Cattley RC; DeLuca J; Elcombe C; Fenner-Crisp P; Lake BG; Marsman DS; Pastoor TA; Popp JA; Robinson DE; Schwetz B; Tugwood J; Wahli W
    Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 1):47-60. PubMed ID: 9629596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
    Cattley RC; DeLuca J; Elcombe C; Fenner-Crisp P; Lake BG; Marsman DS; Pastoor TA; Popp JA; Robinson DE; Schwetz B; Tugwood J; Wahli W
    Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 2):47-60. PubMed ID: 9618323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
    Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
    Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic peroxisome proliferation in rodents and its significance for humans.
    Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ
    Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
    Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
    Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR: a mediator of peroxisome proliferator action.
    Green S
    Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferation of peroxisomes and the hepatocarcinogenic process].
    Palut D
    Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?
    Melnick RL
    Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals.
    Lake BG
    Annu Rev Pharmacol Toxicol; 1995; 35():483-507. PubMed ID: 7598504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
    Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenic aspect of xenobiotic molecules belonging to the peroxisome proliferator family.
    Cherkaoui Malki M; Passilly P; Jannin B; Clémencet MC; Latruffe N
    Int J Mol Med; 1999 Feb; 3(2):163-8. PubMed ID: 9917524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
    Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
    Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of peroxisome proliferators.
    Bieri F; Lhuguenot JC
    Biochimie; 1993; 75(3-4):263-8. PubMed ID: 8507689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARalpha agonist-induced rodent tumors: modes of action and human relevance.
    Klaunig JE; Babich MA; Baetcke KP; Cook JC; Corton JC; David RM; DeLuca JG; Lai DY; McKee RH; Peters JM; Roberts RA; Fenner-Crisp PA
    Crit Rev Toxicol; 2003; 33(6):655-780. PubMed ID: 14727734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
    Perrone CE; Shao L; Williams GM
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators.
    Macdonald N; Holden PR; Roberts RA
    Cancer Res; 1999 Oct; 59(19):4776-80. PubMed ID: 10519382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643.
    Miller RT; Glover SE; Stewart WS; Corton JC; Popp JA; Cattley RC
    Carcinogenesis; 1996 Jun; 17(6):1337-41. PubMed ID: 8681452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment.
    Elcombe CR
    Arch Toxicol Suppl; 1985; 8():6-17. PubMed ID: 3868383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferators: their biological and toxicological effects.
    Dzhekova-Stojkova S; Bogdanska J; Stojkova Z
    Clin Chem Lab Med; 2001 Jun; 39(6):468-74. PubMed ID: 11506454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
    Sterchele PF; Sun H; Peterson RE; Vanden Heuvel JP
    Arch Biochem Biophys; 1996 Feb; 326(2):281-9. PubMed ID: 8611035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.